| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2023 |
3
| Jones Kenneth T (See Remarks) has filed a Form 3 on Zynerba Pharmaceuticals, Inc. |
| 02/09/2023 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 14,926 shares
@ $0
Paid exercise price by delivering 5,145 shares
@ $0.5965, valued at
$3.1k
|
|
| 02/09/2023 |
4
| Fickenscher James E (CFO) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 22,547 shares
@ $0
Paid exercise price by delivering 6,544 shares
@ $0.5965, valued at
$3.9k
|
|
| 02/09/2023 |
4
| Sebree Terri B (President) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 36,044 shares
@ $0
Paid exercise price by delivering 9,973 shares
@ $0.5965, valued at
$5.9k
|
|
| 02/09/2023 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 45,406 shares
@ $0
Paid exercise price by delivering 12,547 shares
@ $0.5965, valued at
$7.5k
|
|
| 02/09/2023 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 18,864 shares
@ $0
Paid exercise price by delivering 5,463 shares
@ $0.5965, valued at
$3.3k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 170,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Sebree Terri B (President) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Sold 24,661 shares
@ $0.5978, valued at
$14.7k
Granted 170,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Fickenscher James E (CFO) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Sold 17,769 shares
@ $0.5978, valued at
$10.6k
Granted 170,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Sold 12,663 shares
@ $0.5978, valued at
$7.6k
Granted 120,000 shares
@ $0 |
|
| 01/25/2023 |
4
| ANIDO ARMANDO (Chairman & Chief Exec. Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Sold 35,453 shares
@ $0.5978, valued at
$21.2k
Granted 250,000 shares
@ $0 |
|
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 14,800 shares
@ $0
Sold 4,289 shares
@ $1.1, valued at
$4.7k
|
|
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|